13F-HR filed by NEA Management Company, LLC
NEA Management Company, LLC filed this 13F-HR for the quarter ended 2014-03-31, filed 2014-05-01, with 28 holding rows worth $2,036,977,000.
- Accession
- 0001512848-14-000004
- Filer
- CIK 1512848
- Filed
- 2014-05-01
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2014
A holdings report, 28 entries on the cover page, a total value of $2,036,977,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,036,977,000 with VALUE read as thousands by filing date, 13F file number 028-14302. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| GROUPON INC | 399473107 | COMMON STOCK | 54,351,582 | $426,116,000 | thousands by filing date | |
| TESARO INC | 881569107 | COM | 9,854,255 | $290,503,000 | thousands by filing date | |
| CVENT INC | 23247G109 | COM | 5,996,212 | $216,763,000 | thousands by filing date | |
| CLOVIS ONCOLOGY INC | 189464100 | COM | 2,279,781 | $157,920,000 | thousands by filing date | |
| EPIZYME INC | 29428V104 | COM | 6,446,089 | $146,777,000 | thousands by filing date | |
| GLYCOMIMETICS INC | 38000Q102 | COM | 8,575,135 | $140,032,000 | thousands by filing date | |
| SUPERNUS PHARMACEUTICALS | 868459108 | COM | 10,650,000 | $95,211,000 | thousands by filing date | |
| HYPERION THERAPEUTICS INC | 44915N101 | COM | 2,884,221 | $74,413,000 | thousands by filing date | |
| FUSION-IO INC | 36112J107 | COMMON STOCK | 7,038,379 | $74,044,000 | thousands by filing date | |
| MILLENNIAL MEDIA INC | 60040N105 | COM | 8,224,752 | $56,915,000 | thousands by filing date | |
| INTERMUNE INC | 45884X103 | COM | 1,341,000 | $44,883,000 | thousands by filing date | |
| SUNESIS PHARMACEUTI-CALS INC | 867328502 | COM | 5,636,573 | $37,258,000 | thousands by filing date | |
| ATRIUM THERAPEUTICS INC | N71546100 | COM | 6,480,171 | $36,483,000 | thousands by filing date | |
| BOINGO WIRELESS INC | 09739C102 | COM | 4,467,960 | $30,293,000 | thousands by filing date | |
| TREVENA INC | 89532E109 | COM | 3,811,691 | $29,960,000 | thousands by filing date | |
| NEKTAR THERAPEUTICS | 640268108 | COM | 1,825,600 | $22,126,000 | thousands by filing date | |
| TARGACEPT INC | 87611R306 | COM | 4,566,666 | $21,692,000 | thousands by filing date | |
| CHANNELADVISOR CORP | 159179100 | COM | 556,692 | $21,010,000 | thousands by filing date | |
| LEXICON PHARMACEUTICALS INC | 528872104 | COM | 11,676,000 | $20,199,000 | thousands by filing date | |
| ZHONE TECHNOLOGIES INC NEW | 98950P884 | COM | 4,781,290 | $20,177,000 | thousands by filing date | |
| Alimera Sciences Inc | 16259103 | CS | 2,255,639 | $17,797,000 | thousands by filing date | The CUSIP as filed is malformed. |
| RIGEL PHARMACEUTICALS INC | 766559603 | COMMON STOCK | 3,243,150 | $12,583,000 | thousands by filing date | |
| OREXIGEN THERAPEUTICS INC | 686164104 | COMMON STOCK | 1,935,300 | $12,579,000 | thousands by filing date | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 5,653,029 | $11,702,000 | thousands by filing date | |
| EXELIXIS INC COM | 30161Q104 | Stock | 2,207,000 | $7,813,000 | thousands by filing date | |
| TRANSCEPT PHARMACEUTICALS IN | 89354M106 | COM | 2,086,755 | $6,427,000 | thousands by filing date | |
| ARQULE INC | 04269E107 | COM | 2,520,316 | $5,167,000 | thousands by filing date | |
| NEUROMETRIX INC | 641255104 | COM | 57,273 | $134,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001512848-14-000004 | this filing | 2014-05-01 | acceptance time not in the bulk data set |